Skip to content

Journal of Psychoactive Drugs

ISSN 0279-1072, 2159-9777

419 papers in the library · 13,118 citations · publishing 1976-2026

Papers

Sort Most recent Most cited

Utilizing Psychedelics to Enhance Well-Being: A Systematic Review

Journal of Psychoactive Drugs March 31, 2025 Samuel Thomson, Nikos Thomacos 11 citations

Psychedelic-assisted therapy is gaining recognition for its potential to enhance human functioning. While most research has focused on psychedelic' therapeutic use for mental illness, this review applies the PERMA Theory of Well-Being to systematically examine their role in enhancing well-being in healthy individuals. The final search of five academic databases was conducted on February 4,...

Mixed-Methods Study of Use and Attitudes About Psychedelics for Therapeutic Purposes Among Low-Income U.S. Veterans Nationally.

Journal of Psychoactive Drugs March 24, 2025 Jack Tsai, Laura Witte, Taylor Fate

There is great public and clinical interest in the use of psychedelics for therapeutic purposes. However, there has been little national study of psychedelic use in the U.S. veteran population. This study used quantitative and qualitative data from a nationally representative survey of 1,031 low-income U.S. veterans who participated in the National Veteran Homeless and Other Poverty Experiences...

Psychedelic Use and Behavioral Addictions.

Journal of Psychoactive Drugs March 15, 2025 Trey Brasher, David Rosen, Marcello Spinella 1 citation

Recent clinical trials on classic psychedelics for depression and anxiety have raised questions about their potential to treat other psychiatric conditions. Evidence from pre-clinical and clinical research suggests psychedelics may help with substance use disorders, with ongoing registered trials. Behavioral addictions, sharing features with substance addictions, may also respond to psychedelic...

DOI: 10.1080/02791072.2025.2474244 (opens in new tab) Full text (opens in new tab) Psychedelics Behavioral addiction Naturalistic Self-report survey

Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation

Journal of Psychoactive Drugs March 14, 2025 Lukas Bobak, Ian Dorney, Alexsandra Kovacevich et al. 2 citations

Long COVID lacks effective pharmaceutical treatment options. Psychedelic treatment for long COVID has received attention given anecdotal reports of neuropsychiatric symptom improvement. This study investigates the use of psilocybin for neuropsychiatric long COVID symptoms, examining online accounts of individuals with reported long COVID using psilocybin. We searched the Reddit communities,...

Meaningful Psychedelic Experiences Predict Increased Moral Expansiveness.

Journal of Psychoactive Drugs March 12, 2025 Will Olteanu, Sam G. Moreton 5 citations

There has been growing interest in understanding the psychological effects of psychedelic experiences, including their potential to catalyze significant shifts in moral cognition. This retrospective study examines how meaningful psychedelic experiences are related to changes in moral expansiveness and investigates the role of acute subjective effects as predictors of these changes. We found...

DOI: 10.1080/02791072.2025.2478095 (opens in new tab) Full text (opens in new tab) Emotion Moral cognition Moral expansiveness Psychedelics

Exploring Motivations, Experiences, and Consequences of Psychedelic Use in Aotearoa New Zealand.

Journal of Psychoactive Drugs March 5, 2025 Ethan Mills, Jai Whelan, Sarah Mcgruddy et al. 3 citations

While interest in psychedelic research has recently increased globally, little is known about use in Aotearoa New Zealand. Therefore, we sought to explore motivations, features of subjective experience, and impact of use. We also aimed to explore and compare positive, typical, and worst experiences. An online survey was completed by 997 individuals who had used at least one classical...

DOI: 10.1080/02791072.2025.2474236 (opens in new tab) Full text (opens in new tab) Aotearoa new zealand Psychedelic Experience Impact +1

Vermont Primary Care Provider Perspectives on Psychedelics — A Cross-Sectional Study

Journal of Psychoactive Drugs March 5, 2025 Josephine Yalovitser, Jonah Levine, Cole Zweber et al. 1 citation

The medical utility of psychedelics has been the subject of significant scientific interest in recent years. While most of these substances remain Schedule I under the Controlled Substances Act, advancements in research have led states to consider expanding legal access, impacting primary care, where patients often seek mental health support and treatment. In July 2023 we conducted a...

DOI: 10.1080/02791072.2025.2474246 (opens in new tab) Cross-sectional study Primary care

Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015–2020

Journal of Psychoactive Drugs March 3, 2025 Wayne Kepner, Patricia Dionicio, Katie Bailey et al. 3 citations

Little is known about ecstasy/MDMA use among Asian American and Pacific Islander populations. Research is important because AAPIs face unique cultural factors that may influence use. We estimated the prevalence and correlates of lifetime ecstasy/MDMA use based on a representative sample of US AAPI adults aged ≥18 from the 2015-2020 National Survey on Drug Use and Health. An estimated 5.1% of...

Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts

Journal of Psychoactive Drugs March 1, 2025 Alexsandra Kovacevich, Ian Dorney, Lukas Bobak et al. 1 citation

Olfactory dysfunction (OD) has become increasingly prevalent since the COVID-19 pandemic, yet effective treatments remain limited. In recent years, anecdotal reports have emerged on the potential benefits of serotonergic psychedelics (lysergic acid diethylamide [LSD], psilocybin, etc.) in improving OD. To date, only one case series in the medical literature has documented this phenomenon. This...

Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption.

Journal of Psychoactive Drugs February 20, 2025 Broc A. Pagni, Andreas Halman, Jerome Sarris et al. 7 citations

The durability of ayahuasca's effects on mental health and the influence of clinical diagnoses on therapeutic response is unclear. Adults with no prior exposure to ayahuasca (n = 66) participating in neo-shamanic ayahuasca ceremonies completed questionnaires at baseline, 7 days, and 1, 6, and 12 months. Mixed models were used to characterize temporal trajectories in mental health, alcohol and...

Setting the Stage for the Inner Journey: Unraveling the Interplay of Contextual Factors and the Intensity of Psychedelic-Induced Ego Dissolution.

Journal of Psychoactive Drugs February 13, 2025 Stanisław Adamczyk, Małgorzata Paczyńska, Anastasia Ruban et al. 2 citations

Psychedelics have the potential to induce profound alterations in cognition, emotionality, and sensory perception. The quality and intensity of these subjective effects exhibit high intra- and inter-individual variability, which can potentially be accounted for by the variability in contexts in which psychedelics are used. Therefore, the aim of the present cross-sectional study was to...

DOI: 10.1080/02791072.2025.2464797 (opens in new tab) Full text (opens in new tab) Ego dissolution Psychedelics hallucinogens Entheogens Psychoactive substances +8

Sex Differences in Religious Beliefs Before and After an Entity Encounter During an Ayahuasca Experience.

Journal of Psychoactive Drugs February 13, 2025 Yitong Xin, Roland R. Griffiths, Alan K. Davis 1 citation

An interesting aspect of entity encounters during psychedelic experiences is their ability to transform one's religious beliefs. However, little is known about sex differences in these transformations. This study investigates sex differences in changes in religious beliefs before and after an entity encounter among ayahuasca users. Data were collected via an anonymous Internet-based survey (N =...

Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use

Journal of Psychoactive Drugs February 7, 2025 Amy Lehrner, Heather Jackson, David S. Mathai et al. 11 citations

The classic psychedelic psilocybin has attracted special interest across clinical and non-clinical settings as a potential tool for mental health. Despite increasing attention to challenging psychedelic experiences, few studies have explored the relevance of shame-related processes with psychedelic use. This prospective, longitudinal study involved sequential, automated, web-based surveys that...

DOI: 10.1080/02791072.2025.2461997 (opens in new tab) Psilocybin Shame Hallucinogen Clinical psychology

Tripping into Treatment: Comparing Initial and Current Motivations for Psychedelic Use

Journal of Psychoactive Drugs February 5, 2025 Daniel J. Kruger, Jeff Albrecht, Jacob S. Aday et al. 3 citations

Psychedelic drugs are currently being explored for their therapeutic potential for a variety of health conditions. The recent increased public interest in psychedelics necessitates empirical investigation into motivations for use among users as well as how motivations may change over time. We asked a large sample of participants reporting naturalistic psychedelic use (N = 1221) about their...

DOI: 10.1080/02791072.2025.2461999 (opens in new tab) Tripping Current fluid Psychotherapist

Oregon’s Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs

Journal of Psychoactive Drugs January 29, 2025 Jason B. Luoma, Kim Hoffman, Adrianne R Wilson-Poe et al. 3 citations

New legal frameworks for supervised psychedelic services are emerging, with Oregon and Colorado implementing programs to train and license psilocybin facilitators. This study describes Oregon's early psilocybin facilitator workforce and assesses state-approved training programs. The Open Psychedelic Evaluation Nexus (OPEN) reviewed Oregon Health Authority-approved training programs and surveyed...

DOI: 10.1080/02791072.2025.2454474 (opens in new tab) Full text (opens in new tab) Healthcare-certification Psilocybin-facilitators Mental-health-workforce Oregon-regulations +4

Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users’ Patterns of Use and Perceived Effects

Journal of Psychoactive Drugs January 29, 2025 Carrie Cuttler, Amanda Stueber, Jonathan J. Simone et al. 3 citations

The ever-changing landscape surrounding legality and accessibility of psychedelics and their increasing popularity make it imperative to better understand the nature of psychedelic use by the general population. To this end, 1,486 eligible respondents (Mage = 29.58, 67.1% male) residing in the United States completed an online survey designed to assess the types of psychedelics used, methods of...

DOI: 10.1080/02791072.2025.2452226 (opens in new tab) Acute effects Administration methods Intentions Psychedelics +4

Experimental Test of Perceptions of Psychedelics by Therapeutic and Recreational Use.

Journal of Psychoactive Drugs January 22, 2025 Mackenzie T Kiniry, Renee E Magnan, Sarah N Elder et al.

Recent research on the potential therapeutic value of psychedelic substances has led to changes in media representation and drug policy in some U.S. states. Yet, little is known about lay perceptions of these substances. The current study aimed to describe health perceptions of psychedelic substances, test differences in perceptions of therapeutic vs. recreational use of psychedelic substances,...

Death Anxiety Among Users and Non-Users of Psychedelics.

Journal of Psychoactive Drugs January 10, 2025 Ana Cláudia Mesquita Garcia, Lucas Oliveira Maia, Everson Meireles et al. 8 citations

This study is a survey-type, cross-sectional study conducted in Brazil (n = 517), with online data collection taking place from April to June 2022. The main objective of this study was to evaluate the death anxiety in users and non-users of psychedelics. To this end, we also assessed the validity and reliability of the Death Anxiety Scale in Brazil. The following instruments were used for data...

DOI: 10.1080/02791072.2025.2451035 (opens in new tab) Full text (opens in new tab) Death anxiety Psychedelics Psychometrics Validity +3

Psychotic-Like Experiences in Young Recreational Users of Ketamine: A Case Study.

Journal of Psychoactive Drugs January 8, 2025 Valerio Ricci, Domenico de Berardis, Sheikh Shoib et al. 4 citations

This study explores the psychotic-like experiences (PLEs) associated with recreational ketamine use among young adults. Ketamine, initially introduced as an anesthetic, is now widely used recreationally for its dissociative effects, raising concerns about its impact on mental health. Ten participants aged 18-24, who used ketamine recreationally multiple times a week, were assessed using the...

DOI: 10.1080/02791072.2025.2449909 (opens in new tab) Full text (opens in new tab) Novel psychoactive drugs Psychotic-like symptoms Schizophrenia Ketamine abuse +3

Ketamine-Assisted Psychotherapy for Antisocial Personality Disorder: A Case Report.

Journal of Psychoactive Drugs January 7, 2025 Matthew Hicks, Heather Zwickey, Ryan Bradley 2 citations

There are currently no evidence-based treatment guidelines for antisocial personality disorder (ASPD). Instead, treatment typically focuses on comorbid conditions. There is currently no literature documenting cases or research, theoretical or otherwise of using ketamine-assisted therapy or any other psychedelic therapy in cases of ASPD. In this case report, a 43-year-old man seeking...

DOI: 10.1080/02791072.2025.2449911 (opens in new tab) Full text (opens in new tab) Antisocial personality disorder Case report Ketamine-assisted psychotherapy Mental health treatment +2

A Psilocybin Experience Gone Wrong: The Importance of Psychedelic Assisted Psychotherapy

Journal of Psychoactive Drugs January 7, 2025 Fernando Espí Forcén

As psilocybin awaits approval by the Food and Drug Administration (FDA), scholars debate whether psychedelic-assisted psychotherapy should be required when prescribing this medicine. Here, we report the case of a patient who underwent a psilocybin experience without psychedelic-assisted psychotherapy, resulting in inpatient psychiatric admission. This case underscores the importance of taking...

DOI: 10.1080/02791072.2025.2449918 (opens in new tab) Psilocybin Hallucinogen Psychotherapist Experiential learning

Unveiling Psychedelics: One of the Most Meaningful Events in Life Associated with Improved Well-Being in Swedish Users

Journal of Psychoactive Drugs January 2, 2025 Petri Kajonius, David Sjöström, Emma Claesdotter-Knutsson 5 citations

In the midst of growing research and societal discourse on psychedelic substances, a consistent finding is reported: A majority of users report profound personal meaning from their experiences. This pioneering study in Sweden, a nation renowned for its strict drug policies, sought to quantify the extent of reported meaningfulness among Swedish psychedelic users. Results revealed that a majority...

DOI: 10.1080/02791072.2024.2444892 (opens in new tab) Mysticism Meaning existential Sample material Clinical psychology +1

Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study.

Journal of Psychoactive Drugs 2025 Jacob S. Aday, Emily K. Bloesch, Alan K. Davis et al. 16 citations

Qualitative studies and anecdotal reports suggest that experiences with ayahuasca, a psychedelic brew found in Central and South America, may be followed by individuals enduringly feeling more grateful and connected to nature. Yet, to date, these changes have been understudied. Here, participants (N = 54) completed validated surveys related to gratitude, nature relatedness, and nature...

DOI: 10.1080/02791072.2024.2312980 (opens in new tab) Full text (opens in new tab) Ayahuasca Positive psychology wellbeing Mystical experiences Biophilia +7

What Predicts Beneficial Outcomes in Psychedelic Use? A Quantitative Content Analysis of Psychedelic Health Outcomes.

Journal of Psychoactive Drugs 2025 Elias C Acevedo, Scott Uhler, Kaitlyn P White et al. 15 citations

Interest in psychedelics and their possible therapeutic potential has been growing. Metaphysical belief theory asserts that these benefits stem from the adoption of comforting supernatural beliefs following a mystical experience. By contrast, predictive self-binding theory suggests that the beneficial outcomes of psychedelics are primarily driven by psychological insights. The present study...

Religion, Psychedelics, Risky Behavior, and Violence.

Journal of Psychoactive Drugs 2025 Sean M. Viña 12 citations

Research has found that psychedelic use is associated with positive behavioral changes, however research has yet to explore the relationship between socio-cultural conditions on this relationship. This paper intends to fill this gap by testing the effects of religious participation and beliefs on the relationship between psychedelic use and behaviors. This study examines the relationship...